Related Experiment Video
Updated: Jan 13, 2026

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
Factors Driving Amyloid Beta Fibril Recognition by Cell Surface Receptors: A Computational Study
Olivia Slater1, Maria Kontoyianni1
1Department of Pharmaceutical Sciences, Southern Illinois University, Edwardsville, IL 62026, USA.
Alzheimer's disease research reveals how beta-amyloid fibrils interact with immune receptors. Fibril structure and pH significantly influence these binding patterns, offering insights into disease progression.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Alzheimer's disease (AD) is characterized by neurotoxic beta-amyloid (Aβ) plaques.
- Insoluble Aβ fibrils (fAβ) activate microglia via receptors like RAGE, TLR2, TLR4, and CD14, leading to inflammation.
Purpose of the Study:
- To elucidate binding patterns of fAβ with RAGE, TLR2, TLR4, and CD14.
- To investigate the influence of fAβ structure (type I vs. II) and pH on receptor binding.
- To explore the impact of familial AD mutations on fAβ structure and receptor interactions.
Main Methods:
- Utilized experimentally resolved fAβ structures (type I and II) from AD brain tissue.
- Performed binding assays with RAGE, TLR2, TLR4, and CD14.
- Investigated the effects of familial mutations (Arctic, Dutch, Iowa, Italian, Flemish) on fAβ structure and binding affinity using in silico modeling.
Main Results:
- TLR2 and RAGE tightly bound both fibril types; TLR4 preferred type I; CD14 preferred type II.
- Binding affinity was pH-dependent for CD14, TLR4, and RAGE, but not TLR2.
- Familial mutations showed varied effects: Arctic, Dutch, and Iowa had similar binding impacts, Italian abrogated binding, and Flemish mutations were not feasible.
Conclusions:
- Immune receptors exhibit adaptability in recognizing fAβ, with fibril structure and pH as key determinants.
- In silico analysis suggests certain familial mutations can form aggregates resembling type I and II structures.
- Findings provide insights into molecular recognition mechanisms in Alzheimer's disease progression.
More Related Videos
08:53Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
Published on: March 21, 2025
06:34A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils